Oncology novel active substance (NAS) launches (cumulative)

Total number of oncology novel active substances launched over a stated multi-year period.

Unit Count Industry Healthcare

Records
6
Regions
3
Period
2005–2024
Sources
1
Verification 6 verified data points Updated 17 Sep 2026 Last verified 17 Sep 2026 Next update Sources typically refresh annually

The chart

Across regions

2 regions on one axis, spaced by time. Below it, the latest value of every region, ranked. Forecasts are dashed with hollow markers; the underlying values are one click away under the chart.

Oncology novel active substance (NAS) launches (cumulative) by region

2 of 3 regions drawn, 2005–2024 to 2020–2024; every region is ranked below

2 regions · 5 observations · 2005–2024 to 2020–2024
Oncology novel active substance (NAS) launches (cumulative) by regionOncology novel active substance (NAS) launches (cumulative) by region. 2 regions on one axis: Global, China. 5 observations from 2005–2024 to 2020–2024, ranging from 37 to 282. Latest values: Global 132 (2020–2024); China 84 (2020–2024). 0 100 200 300 2005 2008 2011 2014 2017 2020 132 84 Global China
Oncology novel active substance (NAS) launches (cumulative) by regionOncology novel active substance (NAS) launches (cumulative) by region. 2 regions on one axis: Global, China. 5 observations from 2005–2024 to 2020–2024, ranging from 37 to 282. Latest values: Global 132 (2020–2024); China 84 (2020–2024). 0 100 200 300 2005 2008 2011 2014 2017 2020 132 84 Global China
Oncology novel active substance (NAS) launches (cumulative) by regionOncology novel active substance (NAS) launches (cumulative) by region. 2 regions on one axis: Global, China. 5 observations from 2005–2024 to 2020–2024, ranging from 37 to 282. Latest values: Global 132 (2020–2024); China 84 (2020–2024). 0 100 200 300 2005 2008 2011 2014 2017 2020 132 84 Global China
View the underlying data
Oncology novel active substance (NAS) launches (cumulative) by region
Region Period Type Value
Global 2020–2024 Actual 132
Global 2015–2019 Actual 79
Global 2005–2024 Actual 282
China 2020–2024 Actual 84
China 2015–2019 Actual 37
Source: IQVIA · CC BY 4.0 · statorigin.org
Embed

Free to embed, including commercially. The attribution bar is part of the chart; it is what keeps the data citable.

<iframe src="https://statorigin.org/embed/healthcare--oncology-novel-active-substance-nas-launches-cumulative--regions" width="100%" height="380" style="border:1px solid #e2e5e3;border-radius:8px" title="Oncology novel active substance (NAS) launches (cumulative) by region" loading="lazy"></iframe>
<p><a href="https://statorigin.org/indicators/oncology-novel-active-substance-nas-launches-cumulative">Oncology novel active substance (NAS) launches (cumulative) by region</a> — data from StatOrigin, CC BY 4.0</p>
Preview embed

Oncology novel active substance (NAS) launches (cumulative) by region

Latest value per region, 2020–2024

3 entries · ranked
Oncology novel active substance (NAS) launches (cumulative) by regionOncology novel active substance (NAS) launches (cumulative) by region. 3 categories, highest is Global at 132. China United States Global 84 85 132
Oncology novel active substance (NAS) launches (cumulative) by regionOncology novel active substance (NAS) launches (cumulative) by region. 3 categories, highest is Global at 132. China United States Global 84 85 132
Oncology novel active substance (NAS) launches (cumulative) by regionOncology novel active substance (NAS) launches (cumulative) by region. 3 categories, highest is Global at 132. China United States Global 84 85 132
View the underlying data
Oncology novel active substance (NAS) launches (cumulative) by region
Category Source Type Value
Global IQVIA Actual 132
United States IQVIA Actual 85
China IQVIA Actual 84
Source: IQVIA · CC BY 4.0 · statorigin.org
Embed

Free to embed, including commercially. The attribution bar is part of the chart; it is what keeps the data citable.

<iframe src="https://statorigin.org/embed/healthcare--oncology-novel-active-substance-nas-launches-cumulative--by-region" width="100%" height="380" style="border:1px solid #e2e5e3;border-radius:8px" title="Oncology novel active substance (NAS) launches (cumulative) by region" loading="lazy"></iframe>
<p><a href="https://statorigin.org/indicators/oncology-novel-active-substance-nas-launches-cumulative">Oncology novel active substance (NAS) launches (cumulative) by region</a> — data from StatOrigin, CC BY 4.0</p>
Preview embed

Every record

All records

6 records · 3 regions · 2005–2024

Oncology novel active substance (NAS) launches (cumulative): every record, grouped by region, newest first.
Period Value Source Type
Global 3 records
2020–2024 132 IQVIA · 31 Dec 2024 actual
2015–2019 79 IQVIA · 31 Dec 2019 actual
2005–2024 282 IQVIA · 31 Dec 2024 actual
United States 1 record
2020–2024 85 IQVIA · 31 Dec 2024 actual
China 2 records
2020–2024 84 IQVIA · 31 Dec 2024 actual
2015–2019 37 IQVIA · 31 Dec 2019 actual

Primary documents

Sources

1 document. Each links to the publisher's own copy.

Document Publisher Published Data points
Global Oncology Trends 2025 IQVIA 6

Cite & reuse

Cite this page

Data on this page is published under CC BY 4.0. You may reuse it, including commercially, provided you attribute it. To cite one figure, open its record: each carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.

StatOrigin. (2026). Oncology novel active substance (NAS) launches (cumulative). Retrieved from https://statorigin.org/indicators/oncology-novel-active-substance-nas-launches-cumulative